| Medical and Health Sciences | Lifetime | 346 | US 190 | 99.98 |
| Medical and Health Sciences | 2021-2025 | 45 | US 22 | 99.99 |
| Hematology | Lifetime | 10 | US 8 | 99.95 |
| Medical Genetics | Lifetime | 44 | US 29 | 99.70 |
| Molecular Biology | Lifetime | 673 | US 411 | 99.66 |
| Public, Environmental and Occupational Health | Lifetime | 526 | US 261 | 99.27 |
| Hematology | 2021-2025 | 2 | US 2 | 99.97 |
| Medical Genetics | 2021-2025 | 14 | US 8 | 99.61 |
| Public, Environmental and Occupational Health | 2021-2025 | 199 | US 80 | 98.29 |
| Molecular Biology | 2021-2025 | 424 | US 116 | 97.90 |
| Oncology | 2021-2025 | 512 | US 225 | 93.10 |
| Immunology | 2021-2025 | 346 | US 118 | 90.83 |
| Emergency Medicine | 2021-2025 | 287 | US 130 | 79.15 |
| Acute Myeloid Leukemia Research | Lifetime | 4 | US 4 | 99.96 |
| Chronic Myeloid Leukemia Treatments | Lifetime | 8 | US 7 | 99.92 |
| Hematological disorders and diagnostics | Lifetime | 4 | US 4 | 99.79 |
| Histone Deacetylase Inhibitors Research | Lifetime | 5 | US 4 | 99.91 |
| Myeloproliferative Neoplasms: Diagnosis and Treatment | Lifetime | 5 | US 5 | 99.91 |
| Acute Lymphoblastic Leukemia research | Lifetime | 12 | US 12 | 99.91 |
| Epigenetics and DNA Methylation | Lifetime | 28 | US 21 | 99.86 |
| Chronic Lymphocytic Leukemia Research | Lifetime | 35 | US 24 | 99.84 |
| Pneumocystis jirovecii pneumonia detection and treatment | Lifetime | 38 | US 12 | 99.60 |
| Neutropenia and Cancer Infections | Lifetime | 29 | US 21 | 99.55 |
| Multiple Myeloma Research and Treatments | Lifetime | 72 | US 40 | 99.49 |
| Protein Degradation and Inhibitors | Lifetime | 60 | US 34 | 99.41 |
| Hematopoietic Stem Cell Transplantation | Lifetime | 106 | US 67 | 99.39 |
| Lymphoma Diagnosis and Treatment | Lifetime | 360 | US 180 | 99.01 |
| Retinoids in leukemia and cellular processes | Lifetime | 131 | US 73 | 98.48 |
| Eosinophilic Disorders and Syndromes | Lifetime | 150 | US 77 | 98.67 |
| Hemoglobinopathies and Related Disorders | Lifetime | 298 | US 149 | 98.11 |
| Blood disorders and treatments | Lifetime | 146 | US 67 | 98.00 |
| Immune cells in cancer | Lifetime | 664 | US 278 | 96.66 |
| Immunodeficiency and Autoimmune Disorders | Lifetime | 722 | US 300 | 97.26 |
| Cancer-related gene regulation | Lifetime | 958 | US 414 | 95.88 |
| Bone and Joint Diseases | Lifetime | 490 | US 196 | 96.31 |
| Vascular Tumors and Angiosarcomas | Lifetime | 682 | US 323 | 92.45 |
| Gestational Trophoblastic Disease Studies | Lifetime | 454 | US 182 | 87.97 |
| Acute Myeloid Leukemia Research | 2021-2025 | 3 | US 3 | 99.98 |
| Myeloproliferative Neoplasms: Diagnosis and Treatment | 2021-2025 | 2 | US 2 | 99.89 |
| Pneumocystis jirovecii pneumonia detection and treatment | 2021-2025 | 1 | US 1 | 99.43 |
| Hematological disorders and diagnostics | 2021-2025 | 1 | US 1 | 98.97 |
| Acute Lymphoblastic Leukemia research | 2021-2025 | 9 | US 7 | 99.86 |
| Chronic Myeloid Leukemia Treatments | 2021-2025 | 9 | US 8 | 99.85 |
| Epigenetics and DNA Methylation | 2021-2025 | 29 | US 14 | 98.85 |
| Histone Deacetylase Inhibitors Research | 2021-2025 | 7 | US 7 | 99.70 |
| Chronic Lymphocytic Leukemia Research | 2021-2025 | 29 | US 16 | 99.52 |
| Hematopoietic Stem Cell Transplantation | 2021-2025 | 18 | US 10 | 99.35 |
| Neutropenia and Cancer Infections | 2021-2025 | 13 | US 7 | 98.24 |
| Multiple Myeloma Research and Treatments | 2021-2025 | 81 | US 39 | 98.90 |
| Protein Degradation and Inhibitors | 2021-2025 | 92 | US 43 | 97.93 |
| Hemoglobinopathies and Related Disorders | 2021-2025 | 91 | US 47 | 97.04 |
| Cancer Genomics and Diagnostics | 2021-2025 | 384 | US 178 | 97.37 |
| Lymphoma Diagnosis and Treatment | 2021-2025 | 311 | US 148 | 97.07 |
| Phagocytosis and Immune Regulation | 2021-2025 | 70 | US 23 | 91.25 |
| Immune cells in cancer | 2021-2025 | 547 | US 113 | 91.45 |
| Blood disorders and treatments | 2021-2025 | 120 | US 31 | 89.94 |
| Sarcoma Diagnosis and Treatment | 2021-2025 | 701 | US 245 | 89.49 |
| Immunodeficiency and Autoimmune Disorders | 2021-2025 | 629 | US 167 | 87.11 |
| Eosinophilic Disorders and Syndromes | 2021-2025 | 591 | US 218 | 80.94 |
| Retinoids in leukemia and cellular processes | 2021-2025 | 296 | US 101 | 73.10 |
| Vascular Tumors and Angiosarcomas | 2021-2025 | 459 | US 164 | 69.03 |
